Liu, Yunxian
Ebinger, Joseph E.
Mostafa, Rowann
Budde, Petra
Gajewski, Jana
Walker, Brian
Joung, Sandy
Wu, Min
Bräutigam, Manuel
Hesping, Franziska
Rupieper, Elena
Schubert, Ann-Sophie
Zucht, Hans-Dieter
Braun, Jonathan
Melmed, Gil Y.
Sobhani, Kimia
Arditi, Moshe
Van Eyk, Jennifer E.
Cheng, Susan
Fert-Bober, Justyna https://orcid.org/0000-0002-2824-5056
Funding for this research was provided by:
Cedars-Sinai Medical Center
Erika J. Glazer Family Foundation
F. Widjaja Family Foundation
Leona M. and Harry B. Helmsley Charitable Trust
National Institutes of Health (K23-HL153888, U54-AG065141, U54-CA260591)
Article History
Received: 20 August 2021
Accepted: 4 December 2021
First Online: 30 December 2021
Declarations
:
: All participants provided written informed consent and all protocols were approved by the Cedars-Sinai institutional review board.
: Petra Budde, Jana Gajewski, Manuel Bräutigam, Franziska Hesping, Elena Rupieper, Ann-Sophie Schubert, and Hans-Dieter Zucht work for Oncimmune, a company that performed the serological assays on the biospecimens that were collected for this study. The remaining authors have no competing interests or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.